Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moderna Therapeutics
Biotech
Moderna's one-two COVID-flu punch matches existing vaccines
Moderna’s combo COVID and flu shot demonstrated strong immunogenicity in a phase 1/2 trial and will speed on to phase 3 before the end of the year.
Annalee Armstrong
Oct 4, 2023 9:55am
Early mRNA vaccine breakthrough wins Nobel Prize for medicine
Oct 2, 2023 8:15am
CureVac hand-picks mRNA flu vaccine but keeps data tucked away
Sep 12, 2023 10:45am
With $1.7B Immatics deal, Moderna bets again on cancer vaccines
Sep 11, 2023 8:12am
Moderna, Excision each enter HIV battle with mRNA, CRISPR tech
Jan 27, 2022 11:02am
Neck and neck with Pfizer, Moderna starts omicron booster trial
Jan 27, 2022 8:00am